Scotts Miracle-Gro
Market Cap
US$12.3b
Last Updated
2021/02/25 00:25 UTC
Data Sources
Company Financials +
Executive Summary
The Scotts Miracle-Gro Company manufactures, markets, and sells consumer lawn and garden products in the United States and internationally. More Details
Snowflake Analysis
Average dividend payer with acceptable track record.
Similar Companies
Share Price & News
How has Scotts Miracle-Gro's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: SMG is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: SMG's weekly volatility (5%) has been stable over the past year.
Market Performance
7 Day Return
-7.7%
SMG
2.1%
US Chemicals
-1.4%
US Market
1 Year Return
91.3%
SMG
33.2%
US Chemicals
37.1%
US Market
Return vs Industry: SMG exceeded the US Chemicals industry which returned 31.6% over the past year.
Return vs Market: SMG exceeded the US Market which returned 34.1% over the past year.
Shareholder returns
| SMG | Industry | Market | |
|---|---|---|---|
| 7 Day | -7.7% | 2.1% | -1.4% |
| 30 Day | -4.5% | 2.3% | 1.6% |
| 90 Day | 30.1% | 6.9% | 7.3% |
| 1 Year | 99.6%91.3% | 36.4%33.2% | 40.2%37.1% |
| 3 Year | 169.2%145.3% | 35.9%15.1% | 62.5%52.1% |
| 5 Year | 258.7%212.0% | 104.4%63.6% | 133.9%108.0% |
Long-Term Price Volatility Vs. Market
How volatile is Scotts Miracle-Gro's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall St
Here's What We Like About Scotts Miracle-Gro's (NYSE:SMG) Upcoming Dividend1 week ago | Simply Wall St
We Like Scotts Miracle-Gro's (NYSE:SMG) Returns And Here's How They're Trending2 weeks ago | Simply Wall St
The Scotts Miracle-Gro Company Just Beat Earnings Expectations: Here's What Analysts Think Will Happen NextValuation
Is Scotts Miracle-Gro undervalued compared to its fair value and its price relative to the market?
25.48x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: SMG ($220.38) is trading above our estimate of fair value ($200.25)
Significantly Below Fair Value: SMG is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: SMG is good value based on its PE Ratio (25.5x) compared to the US Chemicals industry average (28.2x).
PE vs Market: SMG is poor value based on its PE Ratio (25.5x) compared to the US market (21.5x).
Price to Earnings Growth Ratio
PEG Ratio: SMG is poor value based on its PEG Ratio (4.6x)
Price to Book Ratio
PB vs Industry: SMG is overvalued based on its PB Ratio (18.2x) compared to the US Chemicals industry average (2.8x).
Next Steps
Future Growth
How is Scotts Miracle-Gro forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?
5.6%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SMG's forecast earnings growth (5.6% per year) is above the savings rate (2%).
Earnings vs Market: SMG's earnings (5.6% per year) are forecast to grow slower than the US market (20.4% per year).
High Growth Earnings: SMG's earnings are forecast to grow, but not significantly.
Revenue vs Market: SMG's revenue (6.5% per year) is forecast to grow slower than the US market (10.5% per year).
High Growth Revenue: SMG's revenue (6.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SMG's Return on Equity is forecast to be high in 3 years time (34.8%)
Next Steps
Past Performance
How has Scotts Miracle-Gro performed over the past 5 years?
17.2%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: SMG has high quality earnings.
Growing Profit Margin: SMG's current net profit margins (10.7%) are lower than last year (13.6%).
Past Earnings Growth Analysis
Earnings Trend: SMG's earnings have grown by 17.2% per year over the past 5 years.
Accelerating Growth: SMG's earnings growth over the past year (9.8%) is below its 5-year average (17.2% per year).
Earnings vs Industry: SMG earnings growth over the past year (9.8%) exceeded the Chemicals industry -3.4%.
Return on Equity
High ROE: Whilst SMG's Return on Equity (71.19%) is outstanding, this metric is skewed due to their high level of debt.
Next Steps
Financial Health
How is Scotts Miracle-Gro's financial position?
Financial Position Analysis
Short Term Liabilities: SMG's short term assets ($1.7B) exceed its short term liabilities ($1.1B).
Long Term Liabilities: SMG's short term assets ($1.7B) do not cover its long term liabilities ($2.3B).
Debt to Equity History and Analysis
Debt Level: SMG's debt to equity ratio (316.7%) is considered high.
Reducing Debt: SMG's debt to equity ratio has increased from 292.7% to 316.7% over the past 5 years.
Debt Coverage: SMG's debt is well covered by operating cash flow (21.2%).
Interest Coverage: SMG's interest payments on its debt are well covered by EBIT (10.5x coverage).
Balance Sheet
Next Steps
Dividend
What is Scotts Miracle-Gro current dividend yield, its reliability and sustainability?
1.13%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: SMG's dividend (1.13%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.34%).
High Dividend: SMG's dividend (1.13%) is low compared to the top 25% of dividend payers in the US market (3.75%).
Stability and Growth of Payments
Stable Dividend: SMG's dividends per share have been stable in the past 10 years.
Growing Dividend: SMG's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (27.8%), SMG's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: SMG's dividends in 3 years are forecast to be well covered by earnings (29.5% payout ratio).
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
7.3yrs
Average management tenure
CEO
Jim Hagedorn (65 yo)
19.75yrs
Tenure
US$12,289,426
Compensation
Mr. James S. Hagedorn, also known as Jim, has been the Chief Executive Officer at The Scotts Miracle-Gro Company since May 2001 and has been the Chairman of the Board since January 2003. He has been an Exe...
CEO Compensation Analysis
Compensation vs Market: Jim's total compensation ($USD12.29M) is about average for companies of similar size in the US market ($USD10.54M).
Compensation vs Earnings: Jim's compensation has increased by more than 20% in the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman of the Board | 19.75yrs | US$12.29m | 0.061% $ 7.4m | |
| President & COO | 5yrs | US$5.34m | 0.00099% $ 121.5k | |
| Executive VP | 7.33yrs | US$2.95m | 0.015% $ 1.9m | |
| Executive VP of Global Human Resource & Chief Ethics Officer | 18yrs | US$3.48m | 0.014% $ 1.8m | |
| Senior VP & Interim CFO | 0.083yr | no data | 0.024% $ 3.0m | |
| Chief Communications Officer & Executive VP | 12.67yrs | no data | 0.011% $ 1.3m | |
| Senior VP & Chief Marketing Officer | 0.58yr | no data | no data | |
| Senior Vice President of Research & Development | 12.67yrs | no data | no data | |
| Senior Vice President of International Sales | 6.08yrs | no data | no data | |
| Senior Vice President of Global Supply Chain | 10yrs | no data | no data | |
| Senior Vice President of Special Operating Forces | no data | no data | no data | |
| Senior Vice President of Special operations | 0.083yr | no data | no data |
7.3yrs
Average Tenure
59.5yo
Average Age
Experienced Management: SMG's management team is seasoned and experienced (7.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman of the Board | 19.75yrs | US$12.29m | 0.061% $ 7.4m | |
| Independent Director | 6.17yrs | US$285.05k | 0.019% $ 2.3m | |
| Independent Director | 14.5yrs | US$285.05k | 0.016% $ 2.0m | |
| Vice-Chairman of the Board | 8.08yrs | US$285.05k | 0.0085% $ 1.0m | |
| Director | 11.08yrs | US$285.05k | 0.045% $ 5.6m | |
| Independent Director | 13.5yrs | US$285.05k | 0.028% $ 3.5m | |
| Independent Director | 10.25yrs | US$285.05k | 0.038% $ 4.7m | |
| Independent Director | 2.83yrs | US$285.05k | 0.00026% $ 31.9k | |
| Lead Independent Director | 7.08yrs | US$335.10k | 0.020% $ 2.4m | |
| Independent Director | 4.08yrs | US$285.05k | 0.0063% $ 767.2k |
9.2yrs
Average Tenure
65.5yo
Average Age
Experienced Board: SMG's board of directors are considered experienced (9.2 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: SMG insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
The Scotts Miracle-Gro Company's company bio, employee growth, exchange listings and data sources
Key Information
- Name: The Scotts Miracle-Gro Company
- Ticker: SMG
- Exchange: NYSE
- Founded: 1868
- Industry: Fertilizers and Agricultural Chemicals
- Sector: Materials
- Market Cap: US$12.276b
- Shares outstanding: 55.70m
- Website: https://www.scottsmiraclegro.com
Number of Employees
Location
- The Scotts Miracle-Gro Company
- 14111 Scottslawn Road
- Marysville
- Ohio
- 43041
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| SMG | NYSE (New York Stock Exchange) | Yes | Common Shares | US | USD | Jan 1992 |
| SCQA | DB (Deutsche Boerse AG) | Yes | Common Shares | DE | EUR | Jan 1992 |
| 0L45 | LSE (London Stock Exchange) | Yes | Common Shares | GB | USD | Jan 1992 |
Biography
The Scotts Miracle-Gro Company manufactures, markets, and sells consumer lawn and garden products in the United States and internationally. The company operates through three segments: U.S. Consumer, Hawth...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/02/25 00:25 |
| End of Day Share Price | 2021/02/24 00:00 |
| Earnings | 2021/01/02 |
| Annual Earnings | 2020/09/30 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.